Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Outcome of second hematopoietic cell transplantation in Hurler syndrome
S. S. Grewal
, W. Krivit
,
T. E. Defor
,
E. G. Shapiro
,
P. J. Orchard
, S. L. Abel
, L. A. Lockman
, R. S. Ziegler
, K. E. Dusenbery
, C. Peters
CTSI Biostatistics
Neurology
Pediatric Blood & Marrow Transplant & Cellular Therapy
Clinical Behavioral Neuroscience (Pediatrics)
Radiation Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
42
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Outcome of second hematopoietic cell transplantation in Hurler syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hurler Syndrome
100%
Hematopoietic Cell Transplantation
100%
Hurler
50%
Graft Failure
37%
University of Minnesota
25%
α-L-iduronidase
25%
Cyclophosphamide
25%
Long-term Survival
25%
Donor-derived
25%
Metabolic
12%
Activity Level
12%
Marrow
12%
Bone Marrow
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Engraftment
12%
Quality of Life Improvement
12%
Intellectual Disability
12%
Transplant Outcomes
12%
Reconstitution
12%
Enzyme Activity
12%
Multisystem
12%
Busulfan
12%
Conditioning Regimen
12%
Neuropsychological Functioning
12%
Untreated Patients
12%
Life Expectancy
12%
Autosomal Recessive
12%
Unrelated Donor
12%
Median Time
12%
Increased Incidence
12%
Allogeneic Donors
12%
Intellect
12%
Actuarial Survival
12%
Hematopoiesis
12%
Storage Disorders
12%
Matched Sibling
12%
Donor Engraftment
12%
Median Life
12%
Chronic Graft-versus-host Disease (cGVHD)
12%
T Cell Dysfunction
12%
Well Tolerated
12%
Medicine and Dentistry
Hurler Syndrome
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Graft Failure
33%
Engraftment
22%
Cyclophosphamide
22%
Long Term Survival
22%
Levo Iduronidase
22%
T Cell
11%
Quality of Life
11%
Infusion
11%
Morbidity
11%
Life Expectancy
11%
Autosomal Recessive Inheritance
11%
Enzyme Activity
11%
Storage Disease
11%
Graft Versus Host Reaction
11%
Hematopoiesis
11%
Busulfan
11%
Biochemistry, Genetics and Molecular Biology
Cell Transplantation
100%
Hurler Syndrome
100%
Hematopoietic Cell
100%
Iduronidase
22%
Long Term Survival
22%
Cyclophosphamide
22%
Hematopoiesis
11%
Enzyme Activity
11%
Morbidity
11%
Autosomal Recessive Inheritance
11%
Life Expectancy
11%
Busulfan
11%
T Cell
11%
Deficiency
11%
Immunology and Microbiology
Cell Transplantation
100%
Hematopoietic Cell
100%
Engraftment
22%
Long Term Survival
22%
Cyclophosphamide
22%
Graft-Versus-Host Disease
11%
Hematopoiesis
11%
Enzyme Activity
11%
Morbidity
11%
Autosomal Recessive Inheritance
11%
Life Expectancy
11%
T Cell
11%